Stone MM, Vannier AM, Storch SK, et al. Brief report: Meningitis due to iatrogenic BCG infection in two immunocompromised children.. N Engl J Med1995; 333: 561—63.
2.
ISO (International Organization for Standardization)14644-7: cleanrooms and associated controlled environments — Part 7: Separative devices (clean air hood, gloves boxes, isolators, mini-environments) . 2004.
3.
Akers MJ, Moore C.Microbiological monitoring of pharmaceutical cleanrooms:The need for pragmatism . J Adv Appl Contam Control1998; 1: 23—30.
4.
Kopis EMRotation of disinfectants to combat microbial resistance. CleanRooms1996; 10: 48—50.
5.
Kopis EMRegulators put cleanroom sanitizing agents under the microscope. CleanRooms Supplement. 1999.
6.
Kopis EMAnswers to the 10 most common questions regarding microbial control in cleanrooms . CleanRooms. 1997.
7.
Kopis-Sartain E.Regulatory update. Controlled Environments Magazine. March 2005. Available at: http://www.cemag.us/articles.asp?pid=512 . Accessed June 22, 2005.
8.
NIOSH Alert: Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings2004. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No 2004—165.
9.
USP (U.S. Pharmacopeia)Pharmaceutical compounding — sterile preparations (general test chapter 797). In The United States Pharmacopeia 28 rev., and The National Formulary, 23rd edn. Rockville, MD: United States Pharmacopoeial Convention; 2004: 2461—77.
